C.-M. Tsai

Does second-line therapy for non-small cell lung cancer (NSCLC) result in symptom palliation? Analysis of 484 patients from a randomized trial of pemetrexed vs docetaxel

J. R. Pereira, R. Gralla, M. Perry, 2004 .

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer.

H. Groen, J. Milanowski, T. Ciuleanu, 2013, Lung cancer.

A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated

J. Whang‐Peng, R. Perng, J. Shih, 2004, British Journal of Cancer.

Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer

Y-C Wu, K-C Lin, C.-M. Tsai, 2014, British Journal of Cancer.

Title Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety , depression and cancer-related symptoms in patients with lung cancer

Y-C Wu, K-C Lin, C.-M. Tsai, 2015 .

Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3).

G. Scagliotti, A. Shaw, E. Felip, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy.

J. Whang‐Peng, R. Perng, J. Shih, 2004, Journal of Clinical Oncology.

Phase 2 study of ceritinib in ALKi-naïve patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC): Whole body responses in the overall pt group and in pts with baseline brain metastases (BM)

G. Scagliotti, A. Shaw, T. Mok, 2016 .